Rosiglitazone attenuates activation of human Tenon's fibroblasts induced by transforming growth factor -β1

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 250, Issue 8, 2012, Pages 1213-1220

  Fan, Fang ^b   Li, Yuehua ^c   Duan, Xuanchu ^a   Zhao, Tantai ^a   Pan, Dongning ^d   Chen, Huihui ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b HEBEI GENERAL HOSPITAL   (China)

^c 2nd People's Hospital of Yunnan Province   (China)

^d HEBEI UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Alpha smooth muscle actin; Human Tenon's fibroblasts; Rosiglitazone; Transforming growth factor beta

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN TYPE 1; CONNECTIVE TISSUE GROWTH FACTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; ROSIGLITAZONE; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CELL ACTIVATION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TENON FIBROBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TOXICITY TESTING; UPREGULATION;

ACTINS; BLOTTING, WESTERN; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; COLLAGEN TYPE I; CONNECTIVE TISSUE GROWTH FACTOR; FIBROBLASTS; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; HYPOGLYCEMIC AGENTS; PHOSPHORYLATION; PPAR GAMMA; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; SMAD2 PROTEIN; SMAD3 PROTEIN; TENON CAPSULE; THIAZOLIDINEDIONES; TRANSFORMING GROWTH FACTOR BETA1; UP-REGULATION;

EID: 84866363834     PISSN: 0721832X     EISSN: 1435702X     Source Type: Journal    
DOI: 10.1007/s00417-011-1903-6     Document Type: Article

References (27)

1. Lama PJ, Fechtner RD (2003) Antifibrotics and wound healing in glaucoma surgery. Surv Ophthalmol 48:314-346
2. Loon SC, Chew PT (1999) A major review of antimetabolites in glaucoma therapy. Ophthalmologica 213:234-245
3. Wynn TA (2008) Cellular and molecular mechanisms of fibrosis. J Pathol 214:199-210
4. Darby IA, Hewitson TD (2007) Fibroblast differentiation in wound healing and fibrosis. Int Rev Cytol 257:143-179
5. Saika S, Yamanaka O, Okada Y, Tanaka S, Miyamoto T, Sumioka T, Kitano A, Shirai K, Ikeda K (2009) TGFβ in fibroproliferative diseases in the eye. Front Biosci (Schol Ed) 1:376-390
6. Cordeiro MF, Mead A, Ali RR, Alexander RA, Murray S, Chen C, York-Defalco C, Dean NM, Schultz GS, Khaw PT (2003) Novel antisense oligonucleotides targeting TGF-β inhibit in vivo scarring and improve surgical outcome. Gene Ther 10:59-71
7. Cordeiro MF, Gay JA, Khaw PT (1999) Human anti-transforming growth factor-β2 antibody: a new glaucoma anti-scarring agent. Invest Ophthalmol Vis Sci 40:2225-2234
8. Grisanti S, Szurman P, Warga M (2005) Decorin modulates wound healing in experimental glaucoma filtration surgery: a pilot study. Invest Ophthalmol Vis Sci 46:191-196
9. Nakamura H, Siddiqui SS, Shen X, Malik AB, Pulido JS, Kumar NM, Yue BY (2004) RNA interference targeting transforming growth factor-β type II receptor suppresses ocular inflammation and fibrosis. Mol Vis 10:703-711
10. Derynck R, Zhang YE (2003) Smad-dependent and Samdindependent pathways in TGF-β family signaling. Nature 425:577-584
11. Saika S (2006) TGFβ pathobiology in the eye. Lab Investig 86:106-115
12. Cho N, Momose Y (2008) Peroxisome proliferator-activated receptor γ agonists as insulin sensitizers: from the discovery to recent progress. Curr Top Med Chem 8:1483-1507
13. Chinetti G, Fruchart JC, Staels B (2000) Peroxisome proliferatoractivated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation. Inflamm Res 49:497-505
14. Nakamoto M, Ohya Y, Shinzato T, Mano R, Yamazato M, Sakima A, Takishita S (2008) Pioglitazone, a thiazolidinedione derivative, attenuates left ventricular hypertrophy and fibrosis in salt-sensitive hypertension. Hypertens Res 31:353-361
15. Yu J, Zhang S, Chu ES, Go MY, Lau RH, Zhao J,Wu CW, Tong L, Zhao J, Poon TC, Sung JJ (2010) Peroxisome proliferatoractivated receptors gamma reverses hepatic nutritional fibrosis in mice and suppresses activation of hepatic stellate cells in vitro. Int J Biochem Cell Biol 42:948-957
16. Jaster R, Lichte P, Fitzner B, Brock P, Glass A, Karopka T, Gierl L, Koczan D, Thiesen HJ, Sparmann G, Emmrich J, Liebe S (2005) Peroxisome proliferator-activated receptor γ overexpression inhibits pro-fibrogenic activities of immortalised rat pancreatic stellate cells. J Cell Mol Med 9:670-682
17. Burgess HA, Daugherty LE, Thatcher TH, Lakatos HF, Ray DM, Redonnet M, Phipps RP, Sime PJ (2005) PPAR gamma agonists inhibit TGF-β induced pulmonary myofibroblast differentiation and collagen production: implications for therapy of lung fibrosis. Am J Physiol Lung Cell Mol Physiol 288:1146-1153
18. Hinz B (2007) Formation and function of the myofibroblast during tissue repair. J Invest Dermatol 127:526-537
19. Guo B, Koya D, Isono M, Sugimoto T, Kashiwagi A, Haneda M (2004) Peroxisome proliferator-activated receptor-γ ligands inhibit TGF-β1-induced fibronectin expression in glomerular mesangial cells. Diabetes 53:200-208
20. Wang W, Liu F, Chen N (2007) Peroxisome proliferator-activated receptor-γ (PPAR-γ) agonists attenuate the profibrotic response induced by TGF-β1 in renal interstitial fibroblasts. Mediat Inflamm 2007:62641
21. Zhang GY, Cheng T, Zheng MH, Yi CG, Pan H, Li ZJ, Chen XL, Yu Q, Jiang LF, Zhou FY, Li XY, Yang JQ, Chu TG, Gao WY (2010) Peroxisome proliferator-activated receptor-γ (PPAR-γ) agonist inhibits transforming growth factor-beta1 and matrix production in human dermal fibroblasts. J Plast Reconstr Aesthet Surg 63:1209-1216
22. Yamanaka O, Saika S, Ohnishi Y, Kim-Mitsuyama S, Kamaraju AK, Ikeda K (2007) Inhibition of p38MAP kinase suppresses fibrogenic reaction in conjunctiva in mice. Mol Vis 13:1730-1739
23. Jung SA, Lee HK, Yoon JS, Kim SJ, Kim CY, Song H, Hwang KC, Lee JB, Lee JH (2007) Upregulation of TGF-β-induced tissue transglutaminase expression by PI3K-Akt pathway activation in human subconjunctival fibroblasts. Invest Ophthalmol Vis Sci 48:1952-1958
24. Margeli A, Kouraklis G, Theocharis S (2003) Peroxisome proliferator activated receptor-γ (PPAR-γ) ligands and angiogenesis. Angiogenesis 6:165-169
25. Cheng HC, Ho TC, Chen SL, Lai HY, Hong KF, Tsao YP (2008) Troglitazone suppresses transforming growth factor beta-mediated fibrogenesis in retinal pigment epithelial cells. Mol Vis 14:95-104
26. Pan H, Chen J, Xu J, Chen M, Ma R (2009) Antifibrotic effect by activation of peroxisome proliferator-activated receptor-γ in corneal fibroblasts. Mol Vis 15:2279-2286
27. Yamanaka O, Miyazaki K, Kitano A, Saika S, Nakajima Y, Ikeda K (2009) Suppression of injury-induced conjunctiva scarring by peroxisome proliferator-activated receptor γ gene transfer in mice. Invest Ophthalmol Vis Sci 50:187-193